Capsadyn® Expands Distribution With Amazon Launch, Quickly Ranking as #1 New Release in Arthritis Pain Relief

A Gentler Alternative to Traditional Capsaicin Creams Gains Traction on Amazon

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Capsadyn, an innovative treatment for joint and muscle pain based on years of research, has expanded its distribution to Amazon and quickly ranked as the #1 New Release in Arthritis Pain Relief Medications. Capsadyn is a next-generation non-burning capsaicin cream developed by Chorda Pharma Inc. to provide effective pain relief without the common burning sensation associated with traditional capsaicin creams.

Why it matters

Capsaicin creams have long been recognized as effective options for temporary relief of minor arthritis, joint, and muscle pain, but many users discontinue use due to the uncomfortable burning or skin irritation often caused by conventional formulations. Capsadyn was developed to overcome this long-standing limitation, providing a safe and gentle alternative for pain sufferers.

The details

Capsadyn is highly concentrated, so a small amount is designed to deliver effective relief, with each jar providing approximately 50 applications depending on individual use. The fast-absorbing, non-greasy formula is easy to use without mess or medicinal odor. Clinical testing showed that even at the maximum OTC capsaicin strength (0.25%), Capsadyn produced no statistically significant difference in burning sensation compared with a placebo cream containing no capsaicin.

  • Capsadyn launched on Amazon in February 2026.
  • Since launching on Amazon, Capsadyn has quickly gained momentum and is currently ranked as the #1 New Release in Arthritis Pain Relief Medications.

The players

Capsadyn®

An over-the-counter topical analgesic formulated with maximum-strength capsaicin (0.25%) and designed to provide temporary relief from minor arthritis, joint, and muscle pain without the burning sensation associated with traditional capsaicin creams.

Chorda Pharma Inc.

The company that developed Capsadyn, a company focused on innovative, non-opioid approaches to chronic pain management.

Victor Iannello, ScD

The CEO of Chorda Pharma Inc.

Got photos? Submit your photos here. ›

What they’re saying

“Capsadyn is an innovative treatment for joint and muscle pain based on years of research in the lab.”

— Victor Iannello, CEO, Chorda Pharma Inc. (EINPresswire)

The takeaway

Capsadyn provides a safe and gentle alternative to traditional capsaicin creams, offering effective pain relief without the common burning sensation. The product's rapid success on Amazon demonstrates strong consumer demand for innovative, non-opioid pain management solutions.